![Michael J. Manyak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael J. Manyak
Technik-/Wissenschafts-/F&E-Leiter bei Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Profil
Michael J.
Manyak joined Cytogen Corp.
in January 2005 as Vice President of Medical Affairs.
Prior to joining Cytogen, he was Professor of Urology, Microbiology and Tropical Medicine at The George Washington University Medical Center, where he was Chairman of the Department of Urology.
After completing his urological residency at GWUMC, he became an American Foundation for Urological Disease Scholar at the National Cancer Institute and joined the urological staff at GWUMC.
Dr. Manyak has served on the Medicare Coverage Advisory Committee for the Center for Medicare and Medicaid Services, where he was a Member of the Imaging Subcommittee.
He received a presidential appointment to the National Kidney and Urological Disease Advisory Board and was a Voting Member of the Food and Drug Administration Regulatory Panel for Genitourinary and Gastrointestinal Devices.
Dr. Manyak has been a Reviewer for the NIH Special Study Section for Small Business Grants.
He received a BA from the University of Notre Dame and an MD from the University of the East, Manila, Phillipines.
Aktive Positionen von Michael J. Manyak
Unternehmen | Position | Beginn |
---|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
![]() Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Michael J. Manyak
Unternehmen | Position | Ende |
---|---|---|
Viking Systems, Inc.
![]() Viking Systems, Inc. Medical SpecialtiesHealth Technology Viking Systems, Inc. develops, manufactures and markets visualization solutions for complex minimally invasive surgery. The firm sells its visualization system, 3DHD Vision System, under the brand Viking. Its 3DHD Vision System is used by surgeons for complex minimally invasive laparoscopic surgery with applications in urologic, gynecologic, bariatric, cardiac, neurologic and general surgery. The company also manufactures two dimensional digital cameras that are sold to third-party companies who sell to end users through their original design manufacturers. Viking Systems was founded on May 28, 1998 and is headquartered in Westborough, MA. | Direktor/Vorstandsmitglied | 06.10.2007 |
Ausbildung von Michael J. Manyak
University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
![]() Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Viking Systems, Inc.
![]() Viking Systems, Inc. Medical SpecialtiesHealth Technology Viking Systems, Inc. develops, manufactures and markets visualization solutions for complex minimally invasive surgery. The firm sells its visualization system, 3DHD Vision System, under the brand Viking. Its 3DHD Vision System is used by surgeons for complex minimally invasive laparoscopic surgery with applications in urologic, gynecologic, bariatric, cardiac, neurologic and general surgery. The company also manufactures two dimensional digital cameras that are sold to third-party companies who sell to end users through their original design manufacturers. Viking Systems was founded on May 28, 1998 and is headquartered in Westborough, MA. | Health Technology |